$GYHT HALOZYME THERAPEUTICS, INC. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in HALOZYME THERAPEUTICS, INC..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in HALOZYME THERAPEUTICS, INC.. Insider overview, share value development, latest insider transactions and email notifications about new events in HALOZYME THERAPEUTICS, INC. for free.

CIK Number: 0001159036
IRS Number: 880488686
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: GYHT
Company Address: 11388 SORRENTO VALLEY ROAD SAN DIEGO 92121-1345
Former name: GLOBAL YACHT SERVICES INC, date of change: 2001-09-12
Former name: HALOZYME THERAPEUTICS INC, date of change: 2004-03-12

Prev close: $0.00
Average Daily Volume: 0
Days Low: $0.00
Year Low: $0.00
Year High: $0.00

HALOZYME THERAPEUTICS, INC. Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
BIZZARI JEAN-PIERREDirector87,5440shares bought: 58,759 / shares sold: 0 STRONG BUYMay 06 20215 days ago
Connaughton BernadetteDirector32,0130shares bought: 32,013 / shares sold: 0 STRONG BUYMay 06 20215 days ago
Daly James MDirector26,2320shares bought: 70,932 / shares sold: -34,337 STRONG BUYMay 06 20215 days ago
Henderson Jeffrey WilliamDirector52,8390shares bought: 58,759 / shares sold: 0 STRONG BUYMay 06 20215 days ago
Kelley Kenneth JDirector179,8330shares bought: 118,331 / shares sold: -39,671 STRONG BUYApr 14 202127 days ago
LaBarre Michael J.SVP, Chief Technical Officer134,1110shares bought: 150,396 / shares sold: -178,737 SELLMay 03 20218 days ago
Matsuda MasaruSVP, General Counsel17,6990shares bought: 21,400 / shares sold: -9,311 STRONG BUYFeb 17 20213 months ago
MATSUI CONNIEDirector213,9830shares bought: 68,759 / shares sold: -70,000 SELLMay 06 20215 days ago
Posard Matthew L.Director128,9830shares bought: 70,932 / shares sold: 0 STRONG BUYMay 06 20215 days ago
Sun Elaine DSVP, Chief Financial Officer18,0770shares bought: 10,196 / shares sold: -4,059 BUYApr 01 20211 month ago
Torley HelenPresident and CEO587,1600shares bought: 879,675 / shares sold: -441,466 STRONG BUYApr 05 20211 month ago

View all HALOZYME THERAPEUTICS, INC. insiders.

HALOZYME THERAPEUTICS, INC. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
May 06 2021GYHTHALOZYME THERAPEUT ...Posard Matthew L.DirectorGrantA0.005,2300128,983123.8 K to 129 K (+4.23 %)
May 06 2021GYHTHALOZYME THERAPEUT ...MATSUI CONNIEDirectorGrantA0.005,2300213,983208.8 K to 214 K (+2.51 %)
May 06 2021GYHTHALOZYME THERAPEUT ...Henderson Jeffrey WilliamDirectorGrantA0.005,230052,83947.6 K to 52.8 K (+10.99 %)
May 06 2021GYHTHALOZYME THERAPEUT ...Daly James MDirectorGrantA0.005,230026,23221 K to 26.2 K (+24.90 %)
May 06 2021GYHTHALOZYME THERAPEUT ...Connaughton BernadetteDirectorGrantA0.005,230032,01326.8 K to 32 K (+19.53 %)
May 06 2021GYHTHALOZYME THERAPEUT ...BIZZARI JEAN-PIERREDirectorGrantA0.005,230087,54482.3 K to 87.5 K (+6.35 %)
May 03 2021GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...Option ExerciseM11.2911,311127,7010
May 03 2021GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...BuyM11.2911,311127,701134,111122.8 K to 134.1 K (+9.21 %)
Apr 14 2021GYHTHALOZYME THERAPEUT ...Kelley Kenneth JDirectorSellS45.005,000225,000179,833184.8 K to 179.8 K (-2.71 %)
Apr 05 2021GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOOption ExerciseM14.6650,000733,000500,000
Apr 05 2021GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOSellS42.5550,0002,127,250537,160587.2 K to 537.2 K (-8.52 %)
Apr 05 2021GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOBuyM14.6650,000733,000587,160537.2 K to 587.2 K (+9.31 %)
Apr 01 2021GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...Option ExerciseM11.2928,689323,89911,311
Apr 01 2021GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...SellS42.7918,994812,829122,800141.8 K to 122.8 K (-13.40 %)
Apr 01 2021GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...SellS42.119,695408,208141,794151.5 K to 141.8 K (-6.40 %)

View all HALOZYME THERAPEUTICS, INC. insider transactions.